Records containing: Prostatic Neoplasm
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-15Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors (AH-HA)
-
CLINICAL_TRIALS study record update · 2026-04-13An International Prospective Open-label, Multi-center, Randomized, Non-comparative Phase II Study of Lutetium [177Lu] Vipivotide Tetraxetan (AAA617) Alone and Lutetium [177Lu] Vipivotide Tetraxetan (AAA617) in Combination With Androgen Receptor Pathway Inhibitors in Patients With PSMA PET Scan Positive Castration-Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-27ADRIAN: Towards Understanding of ADT Treatment and Dietary Patterns, Circadian Rhythm, Physiological Responsiveness, and Frailty
-
CLINICAL_TRIALS study record update · 2025-12-10Tolerability of Concurrent EBRT + Lu-PSMA for Node-positive Prostate Cancer (PROQURE-1)
-
CLINICAL_TRIALS study record update · 2025-12-02DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations. Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-11-26Investigation of Impact of AI on Prostate Cancer Workflow
-
CLINICAL_TRIALS study record update · 2025-11-17Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
-
CLINICAL_TRIALS study record update · 2025-10-14A Multicenter, Randomized, Controlled Phase 2 Study: Efficacy and Safety of I-131-1095 Radiotherapy in Combination With Enzalutamide in mCRPC Patients Who Are 18F-DCFPyL PSMA-avid, Chemotherapy-naïve, and Progressed on Abiraterone (ARROW )
-
CLINICAL_TRIALS study record update · 2025-09-10A Single Arm, Multicenter, Prospective, Open Label, Longitudinal Phase 3 Study of Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) Combined With Magnetic Resonance Imaging (MRI) Compared to Standard of Care (SOC) for the Detection of Prostate Cancer (PCa).
-
CLINICAL_TRIALS study record update · 2025-08-12A Phase III Prospective Randomized Trial to Evaluate the Impact of Augmented Reality During Robot-assisted Radical Prostatectomy on the Rates of Postoperative Surgical Margins
-
CLINICAL_TRIALS study record update · 2025-06-20Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-05-13A Phase 1/2 Open-label, Multi-center, Dose-escalation Study of Safety, Tolerability, Pharmacokinetics, Dosimetry, and Response to Repeat Dosing of 177Lu-PSMA-R2 Radio-ligand Therapy in Patients With Prostate Specific Membrane Antigen (PSMA) Positive (68Ga-PSMA-R2) Progressive Metastatic Castration-resistant Prostate Cancer, Following Previous Systemic Treatment
-
CLINICAL_TRIALS study record update · 2025-05-0968Ga-PSMA-11 Positron Emission Tomography / Computed Tomography (PET/CT) for Assessment of High Risk or Recurrent Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-02-12EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression
-
CLINICAL_TRIALS study record update · 2025-01-16Phase I/II Trial of Stereotactic Hypofractionated Radiotherapy of the Prostate
-
CLINICAL_TRIALS study record update · 2024-10-09Prostate Cancer Genetic Risk Evaluation and Screening Study (PROGRESS)
-
CLINICAL_TRIALS study record update · 2024-06-2868Ga PSMA-HBED-CC PET in Patients With Biochemical Recurrence
-
CLINICAL_TRIALS study record update · 2024-04-02Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
-
CLINICAL_TRIALS study record update · 2024-03-05Integrating Tissue-based Spatial Information to Elucidate How Obesity-induced Tumour Metabolites Drive Prostate Cancer Progression
-
CLINICAL_TRIALS study record update · 2024-02-1568Ga PSMA-HBED-CC in Intermediate to High-Risk Preprostatectomy Patients
-
CLINICAL_TRIALS study record update · 2024-02-01ClinicalTrials.gov study NCT06236789
-
CLINICAL_TRIALS study record update · 2024-01-30Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate
-
CLINICAL_TRIALS study record update · 2024-01-24Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) PET/CT Utilizing the High Resolution Digital Philips Vereos Scanner, in Patients With Biochemical Recurrence After Radical Prostatectomy
-
CLINICAL_TRIALS study record update · 2023-12-04Urinary and Prostate Microbiotes and Prostate Cancer
-
CLINICAL_TRIALS study record update · 2023-11-14Phase I Trial of Image Guided Focally Dose Escalated Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy